Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Retatrutide is not approved as a medicine in the UK and is not intended for human or veterinary administration
Tirzepatide BNF Drug Monograph
Heart rate The Phase 2 obesity trial reported dose-dependent increases in heart rate
2014;16(S1):8795
However, significant cost, access, and sustainability challenges must be addressed for broader population-level impact
Research Applications Triple hormone receptor (GLP-1/GIP/Glucagon) research Metabolic rate and energy expenditure studies Advanced obesity and weight regulation biology Insulin sensitivity and glucose metabolism research Combination incretin pathway investigations Quality Specifications Purity: 98% (HPLC verified) Compound: Retatrutide Molecular Weight: ~4.9 kDa Form: Lyophilized powder Origin: Made in the USA Testing: Third-party tested in a US laboratory Storage: -20C, protect from light COA: Batch-specific, ISO-accredited laboratory Frequently Asked Questions Q: What makes Retatrutide unique
US$ 23.09
US$ 29.18
US$ 24.54
US$ 23.03
US$ 23.62
US$ 29.21
US$ 20.65
US$ 29.76
US$ 28.70
